Literature DB >> 9132129

[Lacrimal duct recanalization with balloon catheter].

H Hermeking1, M Podder, E Gerke, J M Mackowski, B M Cramer.   

Abstract

In dilation of nasolacrimal duct stenosis materials now being used originally were developed for percutaneous transluminal coronary angioplasty (PTCA). Suitable modifications of the angioplasty equipment could improve therapeutic results and thus influence the area of indication of this new technique. In addition to the standard PTCA equipment, we used a cannula designed to fit the guide wire, leading to less traumatic intubation of the lacrimal duct and allowing radiographic control of the recanalization procedure. Five patients showing relative stenosis and ten patients showing complete obstruction of the nasolacrimal duct were treated by dacryocystoplasty. Clinical and radiographic follow-up was done over a period of 6 months. In a total of seven patients, dilation proved successful. Out of these, four showed stenosis (80% recanalization rate) and three complete obstruction (30% recanalization rate) before dilation. Recanalization by dilation using balloon catheters seems to be possible even in cases of complete nasolacrimal duct obstruction. However, the success rate is considerably lower than in relative stenosis.

Entities:  

Mesh:

Year:  1997        PMID: 9132129     DOI: 10.1007/s003470050083

Source DB:  PubMed          Journal:  Ophthalmologe        ISSN: 0941-293X            Impact factor:   1.059


  2 in total

1.  [Balloon dilatation and Stentimplantation of the nasolacrimal duct for chronic epiphora].

Authors:  U Lachmund; D Ammann-Rauch; A Forrer; M Grob; C Petralli; L Remonda; T Roeren; K Wilhelm
Journal:  Ophthalmologe       Date:  2005-04       Impact factor: 1.059

2.  A novel technique to recanalize the nasolacrimal duct with endodiathermy bipolar probe.

Authors:  Siddharth Agrawal; Sanjiv K Gupta; Vinita Singh; Saurabh Agrawal
Journal:  Indian J Ophthalmol       Date:  2013-12       Impact factor: 1.848

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.